| Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis M Schrag, C Mueller, M Zabel, A Crofton, WM Kirsch, O Ghribi, R Squitti, ... Neurobiology of disease 59, 100-110, 2013 | 362 | 2013 |
| Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer’s disease amyloid plaques S Gowrishankar, P Yuan, Y Wu, M Schrag, S Paradise, J Grutzendler, ... Proceedings of the National Academy of Sciences 112 (28), E3699-E3708, 2015 | 356 | 2015 |
| Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study M Schrag, G McAuley, J Pomakian, A Jiffry, S Tung, C Mueller, HV Vinters, ... Acta neuropathologica 119, 291-302, 2010 | 349 | 2010 |
| Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion M Schrag, C Mueller, U Oyoyo, MA Smith, WM Kirsch Progress in neurobiology 94 (3), 296-306, 2011 | 309 | 2011 |
| Targeted proteomics for quantification of histone acetylation in a lzheimer's disease K Zhang, M Schrag, A Crofton, R Trivedi, H Vinters, W Kirsch Proteomics 12 (8), 1261-1268, 2012 | 227 | 2012 |
| Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia W Kirsch, G McAuley, B Holshouser, F Petersen, M Ayaz, HV Vinters, ... Journal of Alzheimer's Disease 17 (3), 599-609, 2009 | 179 | 2009 |
| Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis M Schrag, T Youn, J Schindler, H Kirshner, D Greer JAMA neurology 72 (10), 1148-1154, 2015 | 176 | 2015 |
| Retracted: Deposition of iron and β‐amyloid plaques is associated with cortical cellular damage in rabbits fed with long‐term cholesterol‐enriched diets O Ghribi, MY Golovko, B Larsen, M Schrag, EJ Murphy Journal of Neurochemistry 99 (2), 438-449, 2006 | 152 | 2006 |
| Management of Intracerebral Hemorrhage: JACC Focus Seminar M Schrag, H Kirshner Journal of the American College of Cardiology 75 (15), 1819-1831, 2020 | 132 | 2020 |
| Management of central retinal artery occlusion: a scientific statement from the American Heart Association B Mac Grory, M Schrag, V Biousse, KL Furie, M Gerhard-Herman, ... Stroke 52 (6), e282-e294, 2021 | 125 | 2021 |
| Stroke risk and risk factors in patients with central retinal artery occlusion P Lavin, M Patrylo, M Hollar, KB Espaillat, H Kirshner, M Schrag American Journal of Ophthalmology 196, 96-100, 2018 | 115 | 2018 |
| The effect of formalin fixation on the levels of brain transition metals in archived samples M Schrag, A Dickson, A Jiffry, D Kirsch, HV Vinters, W Kirsch Biometals 23, 1123-1127, 2010 | 99 | 2010 |
| Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: a meta-analysis in human pathological specimens M Zabel, A Nackenoff, WM Kirsch, FE Harrison, G Perry, M Schrag Free Radical Biology and Medicine 115, 351-360, 2018 | 94 | 2018 |
| Current treatment of central retinal artery occlusion: a national survey TS Youn, P Lavin, M Patrylo, J Schindler, H Kirshner, DM Greer, M Schrag Journal of neurology 265, 330-335, 2018 | 87 | 2018 |
| Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease M Schrag, A Crofton, M Zabel, A Jiffry, D Kirsch, A Dickson, XW Mao, ... Journal of Alzheimer's Disease 24 (1), 137-149, 2011 | 84 | 2011 |
| Perivascular spaces contribute to cognition beyond other small vessel disease markers BS Passiak, D Liu, HA Kresge, FE Cambronero, KR Pechman, KE Osborn, ... Neurology 92 (12), e1309-e1321, 2019 | 79 | 2019 |
| Intravenous fibrinolysis for central retinal artery occlusion B Mac Grory, A Nackenoff, S Poli, MS Spitzer, M Nedelmann, B Guillon, ... Stroke, 2020 | 78 | 2020 |
| A modified “cross-talk” between histone H2B Lys-120 ubiquitination and H3 Lys-79 methylation A Darwanto, MP Curtis, M Schrag, W Kirsch, P Liu, G Xu, JW Neidigh, ... Journal of Biological Chemistry 285 (28), 21868-21876, 2010 | 75 | 2010 |
| The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease C Mueller, W Zhou, A VanMeter, M Heiby, S Magaki, MM Ross, V Espina, ... Journal of Alzheimer's Disease 19 (3), 1081-1091, 2010 | 69 | 2010 |
| Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet JRP Prasanthi, M Schrag, B Dasari, G Marwarha, A Dickson, WM Kirsch, ... Journal of Alzheimer's Disease 30 (1), 167-182, 2012 | 68 | 2012 |
Harry V. VintersDavid Geffen School of Medicine at UCLAEmail verificata su mednet.ucla.edu
